Here’s what you should know:
1. Twenty-two analysts have assigned a ranking to Tenet. Of those, nine are buy ratings, three are sell ratings and 10 are hold ratings.
2. Norman Weekly reports 41 percent of the ratings are positive overall.
3. Among large analysts, BMO Capital Markets gave Tenet an overperform rating Sept. 4, Robert W. Baird gave the stock a buy rating Sept. 28 and JP Morgan gave Tenet an underweight rating Dec. 14.
More articles on transactions/valuations:
Surgery Partners authorizes $50M share repurchase program: 5 quick notes
Alabama ASC files for $135k form D equity financing: 4 key notes
Medical Facilities Corp. paying monthly dividend of $0.09 per share
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.